IARC HPV Working Group. (2014). Primary end-points for prophylactic HPV vaccine trials. International Agency for Research on Cancer.
Chicago Style (17th ed.) CitationIARC HPV Working Group. Primary End-points for Prophylactic HPV Vaccine Trials. Lyon, France: International Agency for Research on Cancer, 2014.
MLA (9th ed.) CitationIARC HPV Working Group. Primary End-points for Prophylactic HPV Vaccine Trials. International Agency for Research on Cancer, 2014.
Warning: These citations may not always be 100% accurate.